Investigating how a specific brain signaling pathway affects recovery from mild head injuries
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
This study is looking at how a certain receptor in brain cells might actually help protect the brain after a mild head injury, instead of causing problems like we used to think, and it aims to find new ways to help people recover better from such injuries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11109593 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a specific receptor, IL-1R1, in neurons following mild closed head injuries. It aims to explore how this receptor may actually protect neurons rather than harm them, which is contrary to previous beliefs about the inflammatory cytokine IL-1. Using advanced mouse models, the study will examine how neuronal IL-1R1 signaling influences brain inflammation, synaptic function, and cognitive recovery after injury. By uncovering these mechanisms, the research hopes to identify new therapeutic strategies for improving recovery from brain injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have suffered mild closed head injuries and may experience cognitive or functional impairments.
Not a fit: Patients with severe head injuries or those with pre-existing severe neurodegenerative conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance recovery and cognitive function in patients who have experienced mild head injuries.
How similar studies have performed: While the approach of investigating neuronal IL-1R1 signaling is relatively novel, similar studies have shown promise in understanding neuroinflammation and its effects on recovery.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Bachstetter, Adam D — University of Kentucky
- Study coordinator: Bachstetter, Adam D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.